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Abstract 
A model to predict the relative levels of respiratory and fecal-oral transmission potentials of 
coronaviruses (CoVs) by measuring the percentage of protein intrinsic disorder (PID) of the M 
(Membrane) and N (nucleoprotein) proteins in their outer and inner shells, respectively, was built 
before the MERS-CoV outbreak. Application of this model to the 2003 SARS-CoV indicated that 
this virus with MPID = 8.6% and NPID = 50.2% falls into group B, which consists of CoVs with 
intermediate levels of both fecal-oral and respiratory transmission potentials. Further validation of 
the model came with MERS-CoV (MPID = 9%, NPID = 44%) and SARS-CoV-2 (MPID = 5.5%, NPID = 
48%) falling into the groups C and B, respectively. Group C contains CoVs with higher fecal-oral 
but lower respiratory transmission potentials. Unlike SARS-CoV, SARS-CoV-2 with MPID = 5.5% 
has one of the hardest outer shells among CoVs. This shell hardness is believed to be responsible 
for high viral loads in the mucus and saliva making it more contagious than SARS-CoV. The hard 
shell is able to resist the anti-microbial enzymes in body fluids. Further searches have found that 
high rigidity of outer shell is characteristic for the CoVs of burrowing animals, such as rabbits (MPID 
= 5.6%) and pangolins (MPID = 5-6%), which are in contact with the buried feces. A closer 
inspection of pangolin-CoVs from 2017-19 reveals that these animals provided a unique window of 
opportunity for the entry of an attenuated SARS-CoV-2 precursor into the human population in 
2017 or earlier, with the subsequent slow and silent spread as a mild cold that followed by its 
mutations into the current more virulent form. Evidence of this lies in the similarity of shell disorder
and genetic proximity of the pangolin-CoVs to SARS-CoV-2 (~90%). A 2017 pangolin-CoV strain 
shows evidence of higher levels of attenuation and higher fecal-oral transmission associated with 
lower human infectivity via having lower NPID (44.8%). Our shell disorder analysis also revealed 
that lower inner shell disorder is associated with the lesser virulence in a variety of viruses.
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Introduction
COVID-19 and SARS-COV-2
In December 2019, it was noticed that patients in Wuhan were falling ill with severe cases of 
pneumonia. The culprit was quickly identified as a novel coronavirus closely related to the 2003 
severe acute respiratory syndrome coronavirus (SARS-CoV). It was labelled SARS-CoV-2, and the 
disease it caused was named coronavirus infectious disease 2019 (COVID-19) (1).  Just as viruses 
closely related to SARS-CoV can be found among animals such as horseshoe bats and civet car 
(2,3), close relatives of SARS-CoV-2 were found in bats (RATG13) and pangolins (4-10). In line 
with the debates on the actual identity of the animal intermediary of SARS-CoV-2(8,9,11), we are 
not only presenting here more evidence of the greater likelihood that pangolins served as an 
intermediary host, but are also able to detect the existence of attenuated strains of CoV closely 
related to SARS-CoV-2. 
Protein intrinsic disorder of the viral shell and the modes of viral transmission  
In 2011-12, before the outbreak of the Middle Eastern respiratory syndrome (MERS)-CoV, a model
that studied the protein intrinsic disorder of the CoV shells was built (3,12). The model measured 
the level of intrinsic disorder in proteins comprising the outer and inner shells of CoVs, M 
(membrane protein found in the outer shell) and N (nucleoprotein constituting the inner shell(3,12)3.
Upon doing so, the CoVs easily clustered into three groups based mainly on the NPID (percentage of 
intrinsic disorder (PID) in N protein). The model predicted that SARS-CoV (MPID = 8.6%; NPID = 
50.2%) would belong to Group B and have intermediate levels of respiratory and fecal-oral 
transmission potentials, whereas other CoVs, such as porcine transmissible epidemic gastroenteritis 
virus (TGEV: MPID = 14%; NPID = 43%), were expected to be in Group C, which includes CoVs 
with lower respiratory but higher fecal-oral transmission potentials (3,12). Then the MERS-CoV 
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came in 2012-13 (13), which presented a great opportunity to test the validity of the disorder-based 
viral transmission model. The model placed MERS-CoV to the group C(14), and, indeed, the 
MERS-CoV reservoir was later found to be among farm animals including camels, which are highly
associated with fecal-oral transmission (13,15). Furthermore, MERS-CoV was found to be not 
easily transmissible among humans (13,14).
Later, another opportunity to test the model came, and this time it came in the form of the COVID-
19 outbreak. Model suggested that the SARS-CoV-2 has to be in group B; i.e., a group with 
intermediate respiratory transmission, given its NPID of 48% (16-18). Furthermore, something else 
strange and puzzling was seen in this virus: i.e., it has one of the hardest outer shells in the sizable 
sample of a wide variety of CoVs we had analyzed (17). This could account for the high levels of 
the SARS-CoV-2 contagiousness, as a hard outer shell is likely to make the virus more resistant to 
the antimicrobial enzymes found in body fluids, such as saliva and mucus (19,20). This should be 
manifested by higher viral load in the saliva and mucus. In agreement with these expectations, viral 
loads in the mucus and saliva for SAR-CoV-2 have been observed in clinical studies to be much 
higher than those of SAR-CoV(21). 
Contagiousness, viral load, and virulence: An enigma
An interesting “competing” finding is the fact that SARS-CoV-2 Spike protein (S) binds to the host 
angiotensin converting enzyme-2 (ACE2) receptor more tightly than the SARS-CoV S protein by 
astonishing 20-30 times (10,22). While both “competing” findings are likely to be true, it is difficult
to link the efficient binding of S to ACE2 with the high level of viral shedding as has been observed
without necessitating a much higher viral load in the lungs. Why is then SARS-CoV-2 (case-fatality
rate (CFR): 2-6%) not more virulent than SARS-CoV (CFR: 9-10%) (23-24) if we assume former's 
much higher viral load in the lungs, given that these two CoV are genetically close and therefore are
likely to produce similar proteins. A more plausible answer would be that there could be a 
discrepancy between viral loads in the lungs and body fluids, as suggested by the shell disorder 
model.  
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Revisiting pangolins, this time, using shell disorder and AI
Nevertheless, the fact that SARS-CoV-2 S binds 20-30 times stronger to ACE2 than the SARS-CoV
S protein (10,22) is an important piece of the puzzle, that we will be addressing in this paper, since 
it is saying that SARS-CoV-2 is highly adapted to human. Furthermore, a recent study has shown 
that part of the sequence pertaining to S may have come from an unrelated human enzyme(23). If 
so, how did it evolve with human? How and when did the virus enter humans? Thus far, these 
important questions have remained unresolved. We shall see that the data arising from the shell 
disorder model that combines empirical proteomic analysis with artificial intelligence (AI) has 
detected a unique window of opportunity, in which an attenuated precursor of SARS-CoV-2 could 
have entered the human population years ago and, thus, initiated a slow and silent spread before 
mutating to become virulent and more contagious form as currently seen. 
Methods 
Protein intrinsic disorder 
An important concept that will be used constantly throughout this paper is protein intrinsic disorder.
Protein intrinsic disorder refers to the lack of structures in parts or a whole functional protein24. 
Disorder play roles in the molecular recognition and protein-protein/DNA/RNA/polysaccharide 
binding (25,26).  There are alternative names, such as natively/naturally 
unfolded/unstructured/flexible proteins(25).
Intrinsic disorder predictor and percentage of intrinsic disorder (PID) calculations
Multiple disorder predictors have been developed, and one the earliest such predictor is PONDR® 
VLXT (www.pondr.com  )(27-29).  This is a neural network (AI: Artificial Intelligence) that has 
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been trained on the sequences of known ordered and disordered proteins. Because PONDR® VLXT 
is highly sensitive to the local sequence peculiarities and protein-protein/DNA/RNA 
interactions(30-31), it has been highly successfully used to analyze viral proteins, especially shell 
proteins of a large variety of viruses, including human immunodeficiency virus (HIV), herpes 
simplex virus (HSV), hepatitis C virus (HCV), Nipah virus (NiV), Ebola virus (EBOV), 1918 HIN1
influenza A virus, CoVs, dengue virus (DENV) and flaviviruses eg yellow fever (YFV), Zika 
(ZIKV) (32-41).
Upon the reading of a protein sequence, PONDR® VLXT will provide intrinsic disorder 
predisposition scores between 0 and 1 for each amino-acid residue. Residues of 0.5 or above are 
those predicted to be disordered (27-29). An important ratio that will be repeatedly used in this 
study is PID (Percentage of Intrinsic Disorder), which is defined as the number of residues 
predicted to be disordered divided by the total number of residues in the protein and multiplied by 
100%. 
Other tools
 The sequences were downloaded from UniProt (https://www.uniProt.org) or GenBank-NCBI 
(https://www.ncbi.nlm.nih.gov/protein).  The sequences were used as inputs to the PONDR® VLXT
server (https://www.pondr.com), and both the results and sequences were downloaded into a 
mySQL server using a program written in JAVA(32).  Sequence similarities were evaluated by 
BLASTP available at NCBI (https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE=Proteins) and 
phylogenetic trees were obtained from EMBI-EBI (https://www.ebi.ac.uk/Tools/msa/clustalo/) 
using the respective sequences as inputs. The N and M phylogenetic trees were annotated with PIDs
using an open-source drawing software, GIMP (https://www.gimp.org/). The evolutionary pathways
were illustrated using open-source platforms, OpenOffice Draw 
(https://www.openoffice.org/download/) and GIMP. Multivariate analysis used to calculate 
correlations was conducted using R statistical package(42) .
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Results
Categorization of CoV based mainly on NPID
The aforementioned categorization of CoVs based on disorder status of their outer and inner shells 
and their transmission modes is summarized in Table 1. While the categorization is done mainly 
based on NPID, statistical analysis picked up a small increase in correlation between PID and levels 
of respiratory transmission potential when MPID (r2=0.80) was added as an independent variable in 
addition to the already used NPID (r2 =0.77)(17). This basically means that the statistics is able to 
detect a small contribution of MPID to the determination of the categorization of CoV as seen in 
Table 1. 
PID: Patterns of CoV evolution dependent on host behaviors 
As reiterated, SARS-CoV-2 and SARS-CoV are in the group B, which includes CoVs that have 
both intermediate levels of fecal-oral and respiratory transmission potentials. However, SARS-
CoV-2 was also observed to have exceptionally hard outer shell. In previous publication, the only 
other CoV detected to have a harder shell than SARS-CoV-2 was HCoV-HKU1. Since then, a 
search have been made to uncover other CoVs with similarly low MPID values. One of these 
uncovered CoVs is rabbit-CoV (HKU14, see Tables 1-2) that has MPID and NPID of 5.4% and 52.2% 
respectively. 
The other CoVs that were uncovered to be closely related to SARS-CoV-2 are bat-RATG13 and 
Pangolin-CoVs. With the exception of SARS-CoV and MERS-CoV that were added for 
comparative purposes, Figure 1 highlights the CoVs that have the lowest MPID values in our new 
CoV sample. The next CoVs that have higher MPID values compared to SARS-CoV-2 are canine 
(Resp)-CoV (MPID = 7%) and bovine-CoV (MPID = 7.8%).  An interesting note is that while 
pangolins and bats are generalized as to be in group C and B respectively, further details of their 
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virus categorization can be found in Table 2, which tells us that 3 of the 4 pangolin CoVs and only 
1 of 4 bat CoV samples fall into group C with the rest being placed to the group B. We are 
beginning to see an emerging pattern of PIDs that is related to the evolutionary pressures faced by 
the various CoVs arising from the behaviors of their various animal hosts. This will be further 
analyzed in section below.
Low MPID:  Burrowing animals and contacts with fecal materials buried in the soil 
A mystery immediately arises: How did SARS-CoV-2 acquire its hard outer shell? What is the 
evolutionary significance of a hard outer shell? An inspection of Tables 1-2 and Figure 1 suggests 
that the clue lies in rabbits, pangolins, and, perhaps, bats, since they have MPID values of 5.7%, 4.5-
6.3% and 4.1% (bat-RATG13 only) respectively. A more careful study, however, tells us that bat-
CoVs have a wide range of MPID values (4.1-17%), whereas all pangolin-CoVs in this sample have 
outer shells as hard as SARS-CoV-2. The hard outer shell is something inherent in pangolin-CoVs 
and rabbit-CoVs, but not necessarily in bat-CoVs.  A new question is then: Why rabbits and 
pangolins? To answer this question, we need to look at the behaviors of these animals. Pangolins 
are ant-eaters that dig into the ground for ant and termite meals(43). Both rabbits and pangolins dig 
burrows in the ground to build their nests. As a result, they are likely to come into contact with 
feces that have been buried in the ground. 
According to shell disorder model, rabbit-CoVs and pangolin-CoVs are associated 
with fecal-respiratory and fecal-oral transmissions, respectively: Buried feces
An apparent paradox then appears when we see that while rabbit-CoV is in group B (intermediate 
fecal-oral and respiratory transmission potentials), most of the pangolin-CoVs are placed into group
C (more fecal-oral transmission potentials) as seen in Tables 1-2 and Figure 1 A-B.  Furthermore, 
a glance at the CoVs in group C makes us realized that pangolin-CoVs are different from CoVs of 
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farm animals, such as the well-studied porcine TGEV, which typically moves very rapidly among 
pigs via fecal-oral routes(3,12,44). Because TGEV does not have to remain in the environment for a
long time, it has a soft outer shell (MPID = 14%) but is clearly has greater fecal-oral potentials (NPID 
= 43%).  In contrast, both pangolin-CoVs and rabbit-CoV are likely to remain in the soil with feces 
for a long time, which necessitates a harder outer shell (pangolin MPID = 4.5-6.3%; rabbit MPID = 
5.7%).  The hard outer shells for rabbit and pangolin CoVs are not coincidental, as they are both 
burrowing animals exposed to the environments, in which the virus can remain active and buried 
along with the feces for a long time.
There are, however, obvious differences between the behaviors of pangolins and rabbits despite the 
fact that both lives in burrows, which could increase the chances of contact with feces that had been
buried in the ground. Pangolins eat ants and termites by the use of their sticky tongues, which could
accidentally touch fecal matters in the ground. Rabbits, in contrast, eat leafs that found above the 
ground. This is likely the reason that the model is detecting greater fecal-respiratory transmission 
for rabbits and greater fecal-oral transmission potential for pangolins, as seen by their NPID values of
44-48% and 52.2% (respectively, Figure 1 B).
Phylogenetic and shell disorder analyses could uncover evolutionary pathways that
would otherwise have been missed if phylogenetic analysis alone is used 
Figure 2 provides phylogenetic trees of M and N proteins annotated with PIDs.  We are able to 
observe that genetically distant CoVs could have the similar N or M PID because of co-evolution 
where different viruses could face the same evolutionary pressures. The mentioned case of 
pangolins and rabbits is an excellent example of this. We can see in Figure 2 that rabbits-CoV and 
pangolin-CoVs are genetically different but yet have similar M PID because of evolutionary 
pressures. 
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Bat-CoVs are genetically and MPID diverse, but its NPID values are around 46-49%: 
Evolutionary bottleneck related to the respiratory transmission potentials
Another interesting example is given by bats. Table 2 shows that bat-CoVs are very genetically 
diverse, especially when one compares their sequence similarities to SARS-CoV-2, with the 
corresponding sequence similarities of pangolin-CoVs. Only RATG13, which is closely related to 
SARS-CoV-2, has a very hard outer shell (MPID = 4.5%) as we can see in our bat samples 
(additional note: bat-RATG13 has 96% genomic similarity to SARS-CoV-2 (11)).  Both bat M 
sequence similarities and MPID values (MPID = 4.5-17%) show a wide range of variability, whereas 
the levels of intrinsic disorder in N protein tell us a different story. Bat-CoVs are genetically 
diverse, as seen in Table 2 (compare N and M sequence similarities) and Figure 2B, but the NPID 
values are normally in the range of 46-49%.  This characteristic is likely the result of the 
evolutionary pressure arising from the minimal levels of respiratory transmission potential 
necessary for the optimal infectivity among bats regardless of the CoV type. 
Examining the possible evolutionary pathways for SARS-CoV and SARS-CoV-2 
using both shell disorder and phylogenetic analysis
 With a better understanding of differences in the evolutionary pressure arising from our knowledge
of MPID and NPID values of the various CoVs, possible pathways of SARS-CoV and SARS-CoV-2 
can be envisaged as seen in Figure 3. While the phylogenetic tree suggests pathways, the M and N 
disorder levels provide the approximate timeline necessary for the mutations to take place based on 
the differences in NPID or MPID values as indicators of the evolutionary pressure. Figure 3 lists out 
some of the possible paths that SARS-CoV, SARS-CoV-2, and their precursors could have taken 
before reaching humans. We are able to observe that genetically dissimilar CoVs could have similar
NPID or MPID because of they evolved under comparative conditions as we seen in the case of MPID 
values of pangolin-CoVs and rabbit-CoV.  
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Path B: A quick transition without evolving much with pangolins – unlikely scenario
A previous study has dismissed the idea that the latest pangolin strain of CoV is a direct 
intermediary of the current SARS-CoV-2 on the basis of a genome-wide phylogenetic study(8). We 
believe that that study was incomplete for two reasons. Firstly, only one pangolin-CoV strain was 
used in the analysis. Secondly, tools that could take into account the peculiarities of evolutionary 
pressure, such as the shell disorder model, were not incorporated into the study. Tables 1-2 and 
Figure 1 show that the various pangolin-CoVs reveal signs of fecal-oral transmission traits despite 
having one strain (2019) that show close similarities to SARS-CoV-2. With their MPID values 
remaining low, most pangolin-CoV strains tend to have low NPID values as wells, which are a 
hallmark of the greater fecal-oral transmission potentials. This is consistent with the mentioned 
behaviors of pangolins, which dig the ground for ants or termites and use their sticky tongues to trap
them as food43. It is not hard to see that fecal materials can easily enter their meals. For this reason, 
the two scenarios related to pangolins as SARS-CoV-2 intermediaries are put forth with the 
evolutionary pressures in mind. Figure 3 illustrates path B as the most direct route, where a 
precursor virus enters the pangolins with NPID values between 46-48% and low MPID. In path B, the 
virus stays a short while among pangolins before moving to humans, as its current form (MPID = 
5.6% and NPID = 48%). In this case, virus cannot stay long among pangolin because doing so would 
forces the virus to have decreased NPID values, as fecal-oral evolutionary pressures set in. 
Path C: A window for pangolin-CoV to enter the human population as an attenuated 
virus with low infectivity
Path C presents a more interesting scenario, where the precursor remains among pangolins for a 
long time and thus facing evolutionary pressures towards fecal-oral transmission with the lowering 
of N PID. In this scenario, however, an entry into the human population necessitate a quiet and slow
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spread because the low N PID provides for low viral loads in both vital organs and body fluids. The 
shell disorder model suggests that in this instance the virus enters the human population as an 
attenuated strain of SAR-CoV-2.  This could explain the reason that the SARS-CoV-2 is very 
adapted to humans. In other words, iIt was given a unique window of opportunity to evolve quietly 
with human for at least a few years. 
Figure 2 and Table 2 tell us that while  pangolin-CoV 2019 is very closely related to SARS-
CoV-2 and is not likely to be an intermediary, there is a greater likelihood that an older pangolin-
CoV strain, particularly  a 2017  one,  could have entered the human populations as seen in Figure 
2B. Why is then the 2019 strain and Bat-RaTG13 that closely related to SARS-CoV-1 both 
genetically and in disorder of M and N? It is  plausible that human SARS-CoV-2 re-entered the bat 
and pangolin populations as suggested in Figure 3C.  This is not unimaginable as both animals 
could have encountered feces of infected humans in form of trash with fruit leftovers and ants. 
Path A: No such attenuating pathway seen for the 2003 SARS-CoV in civet
This opportunity is not seen in the civet cat in the case of SARS-CoV as shown in path A in Figure 
3. There are no tell-tale signs of fecal-oral transmission potentials in the civet cat CoV that we saw 
in pangolins. Nor should we expect this possibility based on the behaviors of the civet cats (3). 
Therefore, as seen in Figure 3A, the civet SARS-CoV must have entered the civet population to 
evolve within it for a moderate timespan to acquire a little more respiratory transmission potential; 
i.e., slight increase in NPID before entering into the human population. Apparently, SARS-CoV did 
not have a chance to evolve and adapt to humans before being detected by the medical community. 
Paths D-E: No such attenuating pathway seen for the SARS-CoV-2 in other animals 
There are also other possible intermediaries for SARS-CoV-2, such as rabbits and cow (Figure 3 
D-E). For such animal intermediaries, specific evolutionary pressures will be encountered, but no 
Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 28 June 2020                   
inherent fecal-oral pressures are seen in these animals, based on the high NPID values of their 
respective CoVs, even though rabbits have a hard outer shell comparable to that of SARS-CoV-2. 
In any case, SARS-CoV-2 is so genetically different from their respective CoVs that it is difficult to
envisage that SARS-CoV-2 did not pick up any of CoV genetic materials along the way, if any of 
these animals had served as an intermediary, even if temporary for a short time.
Discussion
Basis of links between modes of transmission and N disorder: Viral load in body 
fluid
The shell disorder model is a spinoff from its parent research that involved the study of HIV and the
lack of the effective anti-HIV vaccine. It was carefully contrived in 2011-12 from what is known 
about the behavior of farm animals and their CoVs, especially those of porcine (3,12,44). Before the
2003 SARS outbreak, CoVs were not of medical interest, but veterinary data for animal 
coronaviruses were plentiful, because of their threat to the farming community. The reason that 
there are correlations between N disorder and mode of transmission has to do with the necessity of 
having a minimal viral load in the body fluids; i.e., mucus and saliva, before respiratory 
transmission becomes viable17.
Correlations between virulence and N disorder: Viral loads in vital organs
While our shell model provides a link between N disorder and mode of transmission, other studies 
have provided correlations between N disorder and viral virulence. The studies included a wide 
variety of related and non-related viruses, such as NiV, flaviviruses, DENV, and EBOV (3,18,38-
41). There are also hints of links between N disorder and virulence in SARS-CoV and SARS-CoV-
2. While there is still much we need to know about SARS-CoV and SARS-CoV-2, there is much 
stronger evidence of correlations between virulence and inner shell disorder in a fairly large number
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of viruses as aforementioned. This has paved a way for a novel strategy in the development of 
COVID-19 vaccine using shell disorder as describe in our previous paper (18).
“Trojan horse” immune evasion: Quick replication before immune detection
We have described the correlations between inner shell disorder and virulence as a “Trojan horse” 
immune evasion strategy, because it involves rapid replication of the virus before the host immune 
system is able to detect its presence. This, however, often backfires on the virus by leading to the 
death of the host, since large viral loads in vital organs, such as the lungs can, of course, kill the 
host(3,18,38-41). The reason that inner shell disorder provides important means for the rapid 
replication is that inner shell plays vital role in the replication process and disorder is important for 
greater efficiency of protein-protein/RNA/DNA binding (26,45).
Inner shell disorder defines more efficient protein-protein/DNA/RNA interactions 
and therefore more efficient viral replication
The inner shells of many viruses play very similar roles. In the case of CoV N protein, it assists in 
the transportation of other viral proteins to regions near the host Golgi apparatus and ER 
(endoplasmic reticulum), where N helps with the packaging of the viral particles(46). Similarly in 
the case of EBOV, its NP (nucleoprotein) builds a structure that is involved in the transportation of 
viral proteins to the ER(47). All this requires protein-protein/DNA/RNA interactions (48). The 
greater disorder provides important means for greater binding efficiency especially to host 
proteins/DNA/RNA(17,18).
Links among inner shell disorder, virulence, and respiratory transmission: Viral 
loads in body fluids vs. vital organs 
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Virulence is associated with viral load in vital organs, such as the lungs, whereas respiratory 
transmission viability is highly dependent on the viral load in the mucus and saliva. While the viral 
load in vital organs is likely to correlate with the viral load in the body fluids, a heavy viral load in 
vital organs does not necessitate a heavy viral load in body fluids, as the latter contains anti-
microbial and anti-viral enzymes (19,20). The ability of the virus to resist such enzymes is 
dependent on the hardness of the outer shell. The observed greater hardness of M (5.9%) in the case
of SARS-CoV-2 is likely to confer greater resistance to such anti-microbial and anti-viral enzymes. 
This itself could account for the observed large viral load in body fluids. This is why SARS-CoV-2 
is much more contagious than the 2003 SARS-CoV, which has a higher MPID of 8.6%. The question 
is then: Why isn't the immense viral load in body fluids of COVID-19 patients not translated into 
the higher virulence, given that the CFR of SARS-CoV-2 is 2-6% and that of SARS-CoV being 9-
10%? The answer has to do with the predicted discrepancy of viral load in the body fluids and vital 
organs. The shell disorder model tells us that this discrepancy comes not just from the differences in
MPID values but also the slightly lower SARS-CoV-2 NPID (48% vs. 50.2%) that translates into a 
slightly lower ”Trojan horse” effect.
Pangolins offered a window of opportunity for a SARS-CoV-2 precursor to be 
attenuated with greater fecal-oral potentials before entering the human population
With all this in mind we are now ready to re-visit the roles of pangolins. We have mentioned that 
pangolins provided a unique window of opportunity, not seen in other animals, for a SARS-CoV-2 
precursor to enter the human population quietly. Upon the inspection of the various pangolin-CoV 
strains dating back to 2017, the shell disorder model that we have just described detected strains 
that resemble attenuated versions of SARS-CoV-2, given reductions in pangolin-CoV NPID values as
seen in Table 2 and Figures 2C-3B. Even more interestingly, while two previous strains have NPID 
around 46%, which sits at the borderline of group B and C (Figure 1), one of the 2017 strains has 
an NPID of 44.8% (see Table 2 and Figures 2C-3B) that places this strain squarely into the group of 
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CoVs with higher fecal-oral transmission; i.e., the group C. Clinical data from both veterinary and 
medical communities have shown that while CoVs in group C can move rapidly via fecal-oral 
routes in farm animals, such as pigs or camels (3,12,44), it is likely to spread slowly within human 
populations, as it will not have sufficient viral loads to spread rapidly via respiratory modes. We 
have seen this in the case of MERS-CoV spread among humans(3,18). 
Attenuated SARS-CoV-2 strains found in 2017-18 pangolin samples 
The shell model not only makes the case for a strain that spreads slowly within the human population, 
but also points at the strain that had moved into the human population as an attenuated form of virus. 
Again, the strain in the focus here is the 2017 strain of pangolin-CoV with the NPID of 44.8% (Table 2). 
We know that this is an attenuated strain for a number of reasons. Firstly, as seen in Table 2, all 
pangolin-CoV strains are genetically close to SARS-CoV-2 (pangolin-CoV 2019, SARS-CoV, and 
MERS-CoV have about 90%, 80% and 50% genetic similarity to SARS-CoV-2, respectively). 
Secondly, while SARS-CoV-2 and SARS-CoV are consistent with the inner shell attenuation theory 
based on the difference in their NPID values (48% vs. 50%) and CFRs (2-6% vs. 9-10%) (Figure 1C), 
the wealth of our knowledge comes from other viruses and their established correlations between their 
degree of virulence and inner shell disorder. These fairly large variety of viruses include flaviviruses, 
DENV, NiV. and EBOV(38-41).  Summarily, we should be reminded that respiratory transmission 
requires a maximal viral load in mucus and saliva, whereas greater virulence comes with the higher 
viral load in vital organs. 
We have seen attenuated viruses becoming virulent before in polio vaccine
Attenuated viruses mutating to a virulent strain have been seen before. An excellent example of this is 
given by the case of polio vaccines. There are two main polio vaccine type. The first type is the Salk 
vaccine that is made up of inactivated viruses (proteins) that confers only short-term immunity upon 
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several booster shots (2,3). A second type is the Sabin vaccine, which is an attenuated virus that 
provides lifetime immunity to those receiving it (2,3). This, however, comes with a price. It has been 
long known that the inactivated vaccine has mutated to the virulent types (3,49). It should therefore not 
be difficult to envisage an attenuated SARS-CoV-2 that had entered into the human population a few 
years ago before mutating into its current virulent form by acquiring greater disorder at the N protein.   
Conclusions
How did SARS-CoV-2 adapt so well to humans? Through pangolins.
There is a general consensus among scientists that SARS-CoV-2 is somehow very highly adapted to 
humans, so much so that it is suggested that the virus must have entered the human population a long 
time ago (10,23). This is where the mystery begins. When and how did SARS-CoV-2 enter the human 
population? How did it remain in the population for so long without the medical community detecting 
its presence? The shell disorder analysis has important answers to all these questions. A precursor virus
probably entered the human population around 2017 or before. This virus was an attenuated form of 
SARS-CoV-2 that moved slowly, perhaps, within localized and limited communities as a mild cold 
before mutating to its current virulent form. Pangolins are uniquely suited to facilitate such pathway 
through their behaviors that support fecal-oral transmission of viruses. This also adds to the 
overwhelming evidence that the SARS-CoV-2 is not man-made.
Have we discovered a vaccine strain of SARS-CoV-2? Precaution advised
As mentioned, the shell disorder model has detected attenuated SARS-CoV-2 strains based on their
close genetic proximity to the current virus and their lower levels of N disorder. Of particular interest is
a 2017 pangolin-CoV strain seen Table 2 with NPID of 44.8%. Can we suggest that this strain can be
used as a vaccine strain of SARS-CoV-2? Although it is tempting to give a positive answer to this
question, it is needless to say that extra precaution needs to be taken, when such information is used in
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vaccine development. Firstly, as already mentioned, attenuated vaccines have the tendency to mutate to
its virulent types. This is an inherent risk for all attenuated vaccines. Perhaps, additional mutations are
needed to force the NPID to go to even lower values, so as to lessen the chances of the mentioned
converting mutations. Secondly, we do not know if even with the NPID of 44.8% virus is sufficiently
attenuated as a vaccine strain. Currently, we do not have adequate information to address these
questions, and subsequent careful animal and clinical studies are required.
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Figure legends
Figure 1.  N and M PIDs of the various CoVs A. M PID of the CoVs with lowest M PID found in 
the sample. B. N PIDs of the CoVs with hardest outer shell (M) C. N PIDs of pangolin-CoV with 
comparison to SARS-CoV-2 (SARS2) and 2003 SARS-CoV (SARS). Case-fatality rates (CFR) of 
SARS-CoV and SARS-CoV-2 are added in C.   Civet-SARS-CoV and MERS-CoV were shown in 
B only as references.  Pangolin-CoV 2017(**) has been identified as a possible vaccine strain .
Figure 2. Phylogenetic trees of CoV N and M with disorder (PID) annotations. A. M Phylogenetic 
tree  B. N Phylogenetic tree. Pangolin-CoV strains can be cross-referenced and identified using  the 
respective N PIDs or M PIDs in Table 2.
Figure 3.  Possible pathways of  SARS-CoV/SARS-CoV-2 and its precursors in various animals. 
A) Civet cat and SAR-CoV B) Pangolins and SARS-CoV-2- Path B, where the CoV did not have a 
chance to evolve with the pangolins C. Pangolins  and SARS-CoV-2- Path C, where the CoV has 
evolved with pangolins for a long time D. Rabbits and SARS-Cov-2 (Hypothetical purpose only) E.
Bovine and SARS-CoV-2 (Hypothetical purpose only). The timeline for each pathway is adjusted 
for the evolutionary pressures seen in the shell disorder model. Paths A and C are highly plausible 
based on phylogenetic and shell disorder models.
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Table 1. Categorization of coronaviruses by mainly N PID  to predict levels of  respiratory and fecal-oral 
transmission potentials  ( p< 0.001,  r2 = 0.8) . 
Shell
Disorder 
Group
Coronavirus UniProt(U)
/Genbank(G)
Accession Code
(M Proteins)a
UniProt(U)
Genbank(G)
Accession Code
(N)a
M 
PID
N PID Remarks
A HCoV-229E
IBV(Avian)
P15422
P69606
P15130
Q8JMI6
23
10
56
56
Higher levels 
of respiratory 
transmission
lower levels of 
fecal-oral 
transmission 
B Bovine
Rabbit
PEDV (Porcine)
Canine (Resp.)
HCoV-OC43
SARS-CoV
HCoV-NL63
SARS-Cov-2
Batsb
P69704
H9AA37(U)
P59771(U)
A3E2F6(U)
Q4VID2(U)
P59596(U)
Q6Q1R9(U)
P0DTC5(U)
A3EXD6(U)
Q8V432(U)
H9AA59(U)
Q07499(U)
A3E2F7(U)
P33469(U)
P59595(U)
Q6Q1R8(U)
P0DTC9(U)
Q3LZX4(U)
7.8
5.7
8
7
7
8.6
11
5.9
11.2+5.3
53.1
52.2
51
50.5
51
50.2
49
48.2
47.7+0.9
Intermediate 
levels of 
respiratory and 
fecal-oral
transmission
C MHV(Murine)c
Pangolind
MERS-CoV
TGEV(Porcine)
Canine(Ent.)
HCoV-HKU1
Q9JEB4(U)
QIA428617(G)
K0BU37(U)
P09175(U)
B8RIR2(U)
Q14EA7(U)
P03416(U)
QIA48630(G)
K0BVN3(U)
P04134(U)
Q04700(U)
Q0ZME3(U)
8
5.6+0.9
9.1
14
8
4.5
46.8
46.6+1.6e
44.3
43
40
37.4
Lower levels of
respiratory 
transmission
higher levels of
fecal-oral 
transmission 
aUniProt(U): https://www.uniProt.org); (G)GenBank-NCBI (https://www.ncbi.nlm.nih.gov/protein). 
BMore details on the bat samples can be found  in Table 2. 3 out of 4 bat-CoVs are in group B. Note: Large 
standard deviation can be seen for N PID as denoted by “+”
cMHV sits at the borderline and is placed in group C  for convenience.   
dMore details on the pangolin samples can be found  in Table 2. 3 out of 4 bat-CoVs are in group C. 
Standard deviation is denoted by “+”. 
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Table 2. Grouping of pangolin-CoVs and Bat-CoVs by mainly N PID with SARSCoV and SARS-CoV-2 as 
references. 
Coronavirus M PID
(%)
Accession:
UniProt(U)
GenBank(G)
Sequence
Similarity
(%)
N PID
(%)
Accession
UniProt(U)
GenBank(G)
Sequence
Similarity
Group
SARS-CoV-2
SARS-CoV
Civet-SARS-
CoV
5.9
8.6
8.6
P0DTC5(U)
P59596(U)
QZ3TE9(U)
100
90.5
90.1
48.2
50.24
P0DTC9(U)
56
100
90.5
90.01
B
B
B
Pangolin-
CoV
2019
2018
2017**
5.6+0.9a
6.3
4.5
5.9
QIG55948(G)
QIQ54051(G)
QIA48617(G)
98.2
97.7
98.2
46.6+1.6a
48.7
46.3
44.9
46.5
53
QIG55953(G)
QIQ54056(G)
QIA48630(G)
QIA48656(G)
98
93.8
94
93.32
B
C
C
C
Bat-CoV
RATG13
512
HKU3
HKU4
HKU5
11.2+15a
4.1
15.3
7.7
16.4
11.8
Q9JEB4
QHR63303(G)
Q0Q463(U)
Q3LZX9(U)
A3EXA0(U)
A3EXD6(U
99.6
35.5
91
42.7
44.7
47.7+0.9a
48.5
46.5
48
48.5
47.1
QHR63308(G)
Q0Q462(U)
Q3LZX4(U)
A3EXA1
A3EXD7(U)
99.1
29.4
89.6
51.1
47.9
 
B
C
B
B
B
aStandard deviation is denoted by “+”. 
 ** Possible vaccine strain for SARS-CoV-2 detected
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Figure 1
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Figure 2
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